SCHEMBL22567067

SCHEMBL22567067

C=C/C=C\c1cc(C)ccc1/N=C/C

nearest known ligand 0.39

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
▸ KDM4E B2RXH2 2/20 0.39
▸ LMNA P02545 2/20 0.39
▸ MAPT P10636 2/20 0.39
▸ HTT P42858 1/20 0.39
▸ CYP3A4 P08684 1/20 0.34
▸ ADRA2A P08913 1/20 0.34
▸ ALDH1A1 P00352 1/20 0.31
▸ POLB P06746 1/20 0.31
▸ GAA P10253 1/20 0.31
▸ THRB P10828 1/20 0.31
▸ PKM P14618 1/20 0.31
▸ HPGD P15428 1/20 0.31
▸ ALOX15 P16050 1/20 0.31
▸ TSHR P16473 1/20 0.31
▸ ALOX12 P18054 1/20 0.31
▸ MPI P34949 1/20 0.31
▸ HSD17B10 Q99714 1/20 0.31
▸ L3MBTL1 Q9Y468 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14838175 0.82 KDM4E (0.43) KDM4ELMNAMAPTHTTCYP3A4
SCHEMBL25047632 0.82 KDM4E (0.43) KDM4ELMNAMAPTHTTCYP3A4
SCHEMBL17917633 0.75 KDM4E (0.43) KDM4ELMNAMAPTHTTCYP3A4
SCHEMBL20019632 0.74 ALOX5 (0.50) KDM4ELMNAMAPTHTTALDH1A1
SCHEMBL7751617 0.74 ALOX5 (0.50) KDM4ELMNAMAPTHTTALDH1A1
SCHEMBL22375588 0.73 TP53 (0.36) KDM4ELMNAMAPTHTT
SCHEMBL23864857 0.73 TP53 (0.36) KDM4ELMNAMAPTHTT
SCHEMBL21649863 0.72 MAPT (0.43) KDM4ELMNAMAPTHTTCYP3A4
SCHEMBL16130316 0.72 TDP1 (0.45) KDM4EMAPTCYP3A4ALDH1A1GAA
SCHEMBL20852892 0.70 CYP3A4 (0.41) KDM4ELMNAMAPTHTTCYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11065243-B2 Inhibitors of DUX4 induction for regulation of muscle function SONIC MASTER LIMITED (VG) 2021-07-20 — — US disclosed
US-20200330452-A1 Inhibitors of Dux4 Induction for Regulation of Muscle Function SONIC MASTER LIMITED (VG) 2020-10-22 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20200330452-A1 Inhibitors of Dux4 Induction for Regulation of Muscle Function MUSK, MERTK, PRKDC KDM4E 254/4885LMNA 4189/4885MAPT 2823/4885
US-11065243-B2 Inhibitors of DUX4 induction for regulation of muscle function MUSK, MERTK, PRKDC KDM4E 254/4885LMNA 4189/4885MAPT 2823/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback